Life Extension Magazine April 2002
The "war against cancer" is a massive failure
Since 1950, an enormous amount of money has been spent on cancer research. Within the next 12 months, however, more than 554,000 Americans will die from cancer. (Greenlee RT, et al. 2001)
The sad fact is that despite aggressive use of chemotherapy and other conventional treatments, there was little in the way of improvement in long-term survival against most forms of cancer from years 1950 to 1995.
This dismal statistic was revealed in a study published in the Journal of the American Medical Association (Welch HG., et al. 2000). The title of this article is, "Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?" The doctors who authored this study reviewed cancer mortality data from year 1950 to 1995. The purpose of this review was to determine if progress is being made in extending survival time of cancer patients. The results showed that for the most common cancers, the odds of dying in 1995 were about the same as in 1950. The reason more people are now living over five years is because of improved methods of screening and diagnosis, i.e. the cancer is found earlier when it is easier to treat.
This grim survival data, published in the American Medical Association's own journal, indicate that more innovative approaches are needed if we are to discover effective methods of treating this dreaded disease.
Even after cancer patients are declared terminal, the FDA does everything in its power to deny access to alternative approaches. The FDA's hostile actions directly suppress the kind of creative thinking that is so desperately needed to eradicate this insidious disease. Scientists who have discovered innovative therapies face financial ruin and incarceration if they dare offer them before gaining the FDA's official seal of approval.
The regulatory system must be changed
Scientists have identified many ways of controlling cancer cell propagation, but little of this new technology is being used in the clinical practice of medicine. When a scientific discovery is made, drug companies spend years seeking a patent and then more years carrying it through the bureaucratic approval process. The reason why so many cancer patients continue to die is an antiquated regulatory system that causes potential therapies to be delayed or suppressed altogether.
The system needs to be changed if we are to make a realistic attempt to save the 1500 American cancer patients who perish each day. Our long-standing proposal has been to change the law so that anyone can "opt-out" of the FDA's so-called umbrella of "protection." The way this approach would work is that companies could sell novel products with a label clearly stating that they were "Not Approved By The FDA." Consumers who trusted the government could stay with FDA-approved drugs only, while those willing to take a risk would be allowed to try whatever they choose. Companies that made fraudulent claims for products could be prosecuted under the laws that exist today.
We believe that this free market initiative would result in a renaissance in the practice of medicine, analogous to the computer technology revolution that has occurred over the past two decades. In this free market environment, many inexpensive cures would be found for lethal diseases. Greater competition would help eliminate the health care cost crisis that exists today. In this libertarian utopia, when you heard about a medical breakthrough on the news, you would not have to wait years before the therapy might become available.
Today's over-regulated system results in terminally ill people hearing of scientific discoveries that could cure their disease, but are quickly advised by the newscaster that the therapy is years away from FDA approval. We think that terminally ill people should be able to make up their own minds about what drugs they are willing to try.
What cancer patients and their families must do
There are millions of cancer patients alive right now who face possible or probable death in the next 12 months. If you add up family members and friends, there are tens of millions of Americans who should be outraged by an outdated regulatory system that blocks access to potentially life-saving therapies.
The reason the FDA can continue to suppress innovative therapies is that cancer patients have failed to organize for the purpose of abolishing the FDA's arbitrary authority.
The first step to changing today's outmoded system is to organize those who understand the magnitude of this problem into a group that will make an impact on Congressional leaders.
We ask those who are concerned about cancer to register their names and addresses at the website, www.cancervictor.com. If you don't have a computer, send your name and address to:
Cancer Patient Advocates
You will be kept informed on legislation actions to break down the bureaucratic barriers that deny effective therapies to cancer patients.
See and hear the dying cancer patients
Joe Di Stefano and the others have run out of money to pay attorneys. The FDA has economically devastated their business and they are now facing criminal charges. Joe Di Stefano, NC and Daniel Mayer, DO do not have deep pockets, but now have some large legal expenses. They unselfishly devoted themselves to their patients, and were charging next to nothing for the Albarin treatments.
For a donation of $25.00 you will be sent a videotape with footage of a protest held by the Albarin patients in front of the Federal Courthouse in Tampa. Included on the tape are numerous interviews with Albarin patients, pleading for your help so that they might live.
To help battle FDA tyranny, please send your tax-deductible donation to:
Freedom of Choice Fund / FLA
The video tape will shock you, as you hear multiple testimonials from cancer patients who believe they owe their lives to the pioneers who developed Albarin.
My personal comments. . .
As soon as I heard about these outrageous FDA raids, I flew to Tampa and spent two weeks helping Joe Di Stefano organize his legal defense. I spoke with numerous cancer patients and reviewed the results of studies indicating that Albarin was working exceedingly well.
Dr. Danhof stated that Albarin is almost identical to Acemannon, an aloe drug patented by Carrington Labs, where Danhof used to work. He explained that the difference is Acemannon uses only the middle part of the leaf, the filet as its called, which has a high water content, so it's more diluted than the extract used in Albarin, which utilizes the whole leaf. This is the only way to get the large molecule constituents that work well in the treatment of cancer. Danhof stated that Acemannon's safety had been verified by numerous animal studies and had been approved by the Department of Agriculture for use in the treatment of feline leukemia and in the treatment of sarcomas, for which it worked very well.
Dr. Danhoff stated that Albarin had a history of being used successfully since 1996 in humans in over 600 patients in the USA, Canada, Mexico, Holland, Belgium, Germany and China. He emphasizes that he goes to great lengths in his lab using spectral chromatography and other analytic methods to produce a safe, pure substance, and that he has tested every batch on himself or his colleague first before giving it to any patients. All aloe utilized was certified organic. He emphasizes that it took him over 20 years to perfect the process of producing Albarin, which is extracted through a freeze-drying process.
Dr. Danhof states that the chill that patients notice from Albarin is "not a side effect, its just a sign that the immune system is responding favorably, and when you contrast this with the side effects of chemotherapy drugs such as severe nausea, vomiting and other problems stemming from toxicity, which Albarin doesn't have, it's a vast improvement, and a big reason why patients like it so much."
Dr. Danhof provided a statement to me detailing his extensive experience as a medical researcher and professor of medicine at Southwestern Medical School, the University of Texas Health Science Center in Dallas between 1953 and 1983 where he first started studying aloe.
You can find out more about Albarin, including several key studies cited by Dr. Danhof, by accessing the International Advocates For Health Freedom website, www.iahf.com-go to the Albarin Raid section.
Greenlee RT, et al. Cancer statistics, 2001. CA Cancer J Clin 2001 Jan-Feb;51(1):15-36.